Results 161 to 170 of about 22,377,175 (350)
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
Molecular Oncology, EarlyView.The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy +9 more
wiley +1 more source
Improved Remixing Process for Domain Adaptation-Based Speech Enhancement by Mitigating Data Imbalance in Signal-to-Noise Ratio [PDF]
Li Li, Shogo Seki
openalex +1 more source
Empathic choice involves vmPFC value signals that are modulated by social processing implemented in IPL [PDF]
, 2012 Vanessa Janowski +2 more
openalex +1 more source
Wavelets and signal processing
IEEE Signal Processing Magazine, 1991 O. Rioul, M. Vetterli
semanticscholar +1 more source
Emerging role of ARHGAP29 in melanoma cell phenotype switching
Molecular Oncology, EarlyView.This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster +3 more
wiley +1 more source
Electromyography (EMG) Signal Processing to Evaluate Low-Frequency Tremors. [PDF]
Sensors (Basel)O'Sullivan S +3 more
europepmc +1 more source
Reviewer #1 (Public review): Multi-level processing of emotions in life motion signals revealed through pupil responses [PDF]
Tian Yuan, Li Wang, Yi Jiang
openalex +1 more source
Colony Stimulating Factor Signaling Process [PDF]
, 2020 National Cancer Institute
openalex +1 more source
Molecular Oncology, EarlyView.In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source